Early Phase Clinical Trials Unit
The Early Phase Clinical Trials Unit (EPCTU) aims to support the translation of research findings in to clinical practice.
The EPCTU is a specialist, dedicated clinical trials unit, supporting early phase research integrating oncology and haematology as a seamless service.
Recruiting over 150 patient per year, our key remit is the testing of novel therapies, on a bespoke 15 bedded ward incorporating a sample handling laboratory. Under the direction of our Principle Investigators, who are world-leading clinicians and clinician scientists, a team of research nurses and clinical fellows work across the broad portfolio of studies, providing expertise in patient management and protocol compliance. By taking a systematic approach to data capture, data entry is highly compliant.
Supporting academic and commercial research, the group operates as part of the Oxford University Department of Oncology, Oxford University Hospitals NHS Foundation Trust, ECMC, and BRC
If you would like to find out more, please contact the EPCTU team.
EPCTU Contact Details
EPCTU Lead: Sandie Wellman
More about EPCTU